The Efficacy of Mannitol Combined with 6-Aminocaproic Acid in the Treatment of Patients with Cerebral Hemorrhage and Its Impact on Immune Function
- PMID: 35865345
- PMCID: PMC9296274
- DOI: 10.1155/2022/7396310
The Efficacy of Mannitol Combined with 6-Aminocaproic Acid in the Treatment of Patients with Cerebral Hemorrhage and Its Impact on Immune Function
Retraction in
-
Retracted: The Efficacy of Mannitol Combined with 6-Aminocaproic Acid in the Treatment of Patients with Cerebral Hemorrhage and Its Impact on Immune Function.Evid Based Complement Alternat Med. 2023 Sep 27;2023:9815603. doi: 10.1155/2023/9815603. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37808141 Free PMC article.
Abstract
Objective: To determine the efficacy of Mannitol combined with 6-aminocaproic acid in the treatment of patients with cerebral hemorrhage, as well as its impact on the immune system.
Methods: The study subjects consisted of 122 patients with early intracerebral hemorrhage treated in our hospital from April 2019 to April 2022. Based on the different admission times, the participants were randomly divided into the control group and the study group in a ratio of 1:1. 6-Aminocaproic acid was used to treat patients in the control group, while Mannitol along with 6-aminocaproic acid was used to treat patients in the study group. Short form-36 health survey (SF-36) scores, hematoma volume changes, National Institutes of Health Stroke Scale (NIHSS), and Mini-Mental State Examination (MMSE) scores, clinical efficacy, and changes in the immune function in patients from the two groups were analyzed and compared.
Results: The total efficacy of treatment in the study group was significantly higher than that in the control group (x 2 = 9,375, P < 0.001). Patients in the study group had significantly higher scores in social function, mental health, physical function, and physiological function compared to those in the control group (P < 0.05). After treatment, there was a significant reduction in NIHSS scores in patients from both groups, but a greater reduction was seen in patients from the study group (P < 0.05). After 2 weeks of treatment, the volume of cerebral edema was significantly smaller in patients from the study group than in those from the control group (P < 0.05). Before treatment, there was no significant difference in the number of CD4+ and CD8+ T lymphocytes between patients in the two groups. However, after treatment, patients in the study group had higher numbers of CD4+ T lymphocytes and lower numbers of CD8+ T lymphocytes compared to those in the control group (P < 0.05).
Conclusions: The combination of Mannitol and 6-aminocaproic acid appears to be very efficacious in the treatment of cerebral hemorrhage. It improves immune function, reduces neurological damage, and minimizes the volume of cerebral edema.
Copyright © 2022 Buxian Tian et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
A Retrospective Cohort Study of Neuroendoscopic Surgery versus Traditional Craniotomy on Surgical Success Rate, Postoperative Complications, and Prognosis in Patients with Acute Intracerebral Hemorrhage.Comput Intell Neurosci. 2022 Aug 5;2022:2650795. doi: 10.1155/2022/2650795. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 36035835 Free PMC article.
-
Efficacy of Concurrent Utilization of Mannitol and Nimodipine in Treating Hypertensive Intracerebral Hemorrhage and Its Effects on Neurological Function.Psychiatry Clin Psychopharmacol. 2025 Apr 16;35(2):117-123. doi: 10.5152/pcp.2025.24986. eCollection 2025 Jun. Psychiatry Clin Psychopharmacol. 2025. PMID: 40503470 Free PMC article.
-
Tripartite intensive intervention for prevention of rebleeding in elderly patients with hypertensive cerebral hemorrhage.World J Clin Cases. 2021 Nov 26;9(33):10106-10115. doi: 10.12998/wjcc.v9.i33.10106. World J Clin Cases. 2021. PMID: 34904080 Free PMC article.
-
Medical interventions for traumatic hyphema.Cochrane Database Syst Rev. 2019 Jan 14;1(1):CD005431. doi: 10.1002/14651858.CD005431.pub4. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2023 Mar 13;3:CD005431. doi: 10.1002/14651858.CD005431.pub5. PMID: 30640411 Free PMC article. Updated.
-
Efficacy of desferrioxamine mesylate in intracerebral hematoma: a systemic review and meta-analysis.Neurol Sci. 2022 Dec;43(12):6771-6782. doi: 10.1007/s10072-022-06324-0. Epub 2022 Aug 25. Neurol Sci. 2022. PMID: 36006553 Free PMC article.
Cited by
-
Retracted: The Efficacy of Mannitol Combined with 6-Aminocaproic Acid in the Treatment of Patients with Cerebral Hemorrhage and Its Impact on Immune Function.Evid Based Complement Alternat Med. 2023 Sep 27;2023:9815603. doi: 10.1155/2023/9815603. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37808141 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous